Efficient Induction of Autophagic Cell Death through Oxidation Therapy by a Codelivery ROS-Responsive Nanoplatform
Molecular Pharmaceutics · 2025
DOI: 10.1021/acs.molpharmaceut.5c01064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Fengjuan Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Jiangyin Clinical College of Xuzhou Medical University, Jiangyin 214400, China. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Nanoparticles, Paclitaxel, Autophagic Cell Death. Die Arbeit nennt 38 Literaturangaben. Gefördert von: the Project supported by the Wuxi "Taihu talent plan" for excellent medical expert team, National Natural Science Foundation of China, the key research and development program of Jiangsu province.
Abstract (Originalsprache)
Previous studies have demonstrated that induction of reactive oxygen species (ROS) significantly enhances the cytotoxicity of paclitaxel (Ptx). Tetrandrine (Tet), a potent ROS inducer, synergistically enhances the antitumor effects of Ptx. To codeliver Ptx and Tet, which have low solubility, high systemic toxicity, and poor tumor selectivity, we designed a tumor microenvironment-activatable prodrug-based delivery system. A ROS-responsive prodrug was developed by the conjugation of Ptx to a biocompatible polymer (1,2-distearoyl-sn-glycero-3-phosphoethanolamine-poly(ethylene glycol), DSPE-PEG) via the ROS-cleavable thioketal (TK) linker, which could self-assemble into core-shell nanoparticles with Tet in the inner core to form redox-responsive Ptx/Tet-coloaded nanoparticles (P/T-NPs). The synergistic anticancer mechanism of Ptx and Tet was systematically investigated by cytotoxicity assays, ROS detection, mitochondrial tracing, transmission electron microscopy, and both in vitro and in vivo experiments. Cell uptake of P/T-NPs increased in a time-dependent manner, with partial accumulation observed in the mitochondria. The targeted release of Tet in tumor sites with high ROS levels could further elevate intracellular ROS, which in turn accelerated the cleavage of the TK linker and promoted the release of Ptx, thereby enhancing its antitumor effect. P/T-NPs showed superior cytotoxicity, which is strongly correlated to the superior autophagy-inducing ability of P/T-NPs. Moreover, P/T-NPs effectively inhibit the tumor growth compared to either the free drug or their combination therapy. This study integrates tumor microenvironment activation, self-amplified drug release, and ROS-enhanced chemotherapy into a single nanoplatform, offering a promising strategy for targeted cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, The Jiangyin Clinical College of Xuzhou Medical University, Jiangyin 214400, China.
- Department of Gastroenterology, Xishan People's Hospital of Wuxi City, Wuxi 214104, China.
- Department of Pharmaceutics, School of Pharmacy, Nanjing Medical University, Nanjing 210006, China.
- Department of Pathology, Huadong Hospital, Fudan University, Shanghai 200040, China.
ORCID-Profile: Huae Xu
Förderung
- the Project supported by the Wuxi "Taihu talent plan" for excellent medical expert team
- National Natural Science Foundation of China
- the key research and development program of Jiangsu province
Zitieren
APA
Chen, F., Yu, N., Lin, Y., Wang, P., Gao, H., Zhu, S., Wu, T., Xu, H., & Liu, P. (2025). Efficient Induction of Autophagic Cell Death through Oxidation Therapy by a Codelivery ROS-Responsive Nanoplatform. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01064
Vancouver
Chen F, Yu N, Lin Y, Wang P, Gao H, Zhu S, et al. Efficient Induction of Autophagic Cell Death through Oxidation Therapy by a Codelivery ROS-Responsive Nanoplatform. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c01064
BibTeX
@article{Chen2025,
author = {Chen, Fengjuan and Yu, Na and Lin, Ya and Wang, Pengpeng and Gao, Huimin and Zhu, Shuangfei and Wu, Ting and Xu, Huae and Liu, Pengfei},
title = {Efficient Induction of Autophagic Cell Death through Oxidation Therapy by a Codelivery ROS-Responsive Nanoplatform},
journal = {Molecular Pharmaceutics},
year = {2025},
doi = {10.1021/acs.molpharmaceut.5c01064}
}
EUVIMED